People still do not understand how a lab works, how sequencing a complete genome still remains a very, time, energy, memory, staff consuming activity.

FORBES: So Much Hype, So Little Substance

Further more exome sequencing is a questionable working model as companies will now be able to sequence a complete genome at a lower cost than one utilizing array exome capture and potential bias, why a company would offer that as the preferred service is odd.

FORBES: PerkinElmer Enters DNA Sequencing Market